하지 임플란트 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 바이오소재별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Lower Extremity Implants Market Growth & Trends:

The global lower extremity implants market size is anticipated to reach USD 16.25 billion by 2030 and projected to grow at a CAGR of 2.96% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of robotic assisted surgeries is anticipated to boost market growth. In June 2024, Meril, a medical devices company based in Gujarat, launched a surgical robotic technology called MISSO. MISSO will offer real-time support to surgeons during knee replacement procedures. The incorporation of AI in this system has enabled an 83% reduction in pre-operative planning time and has led to enhanced customization.

Increasing participation in sports across the globe is boosting market growth. According to the Aspen Institute report, the rate of sports engagement among Asian children aged 6 to 12 rose to 42% in 2022, an increase from 35% in 2019 prior to the pandemic. Similarly, according to the SGB Media article, the overall participation rate of teams in the U.S. (6 years and older) increased by 3.7% to reach 70.8 million, which matches the level seen in 2019 before the pandemic and represents the highest number of people participating in team sports in the past ten years. As participation in sports and recreational activities grows globally, there is a corresponding rise in sports-related injuries, particularly involving the lower extremities. For instance, the annual injury incidence rate averaged 5.40 injuries per 100,000 participants. Men experienced a higher incidence rate at 6.44 per 100,000 compared to women at 3.34 per 100,000. Sporting activities had an incidence rate of 9.88 per 100,000, which was higher than cycling at 2.81 per 100,000, fitness at 0.21 per 100,000, or walking at 0.03 per 100,000.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. Furthermore, increasing knee replacement surgeries are fostering market growth. For instance, the Agency for Healthcare Research and Quality reports that over 600,000 knee replacement surgeries are carried out annually in the U.S. In addition, the increasing funding from government and non-government bodies to develop advanced product is driving market growth. For instance, in June 2022, Towfighian was awarded a USD 2.3 million grant from the National Institutes of Health (NIH) for conducting research on smart knee replacements.

The expansion of health insurance coverage in various regions, including coverage for orthopedic procedures, makes these surgeries more accessible to a broader population. Moreover, rising incidence of chronic diseases such as rheumatoid arthritis are escalating market growth. According to the 2023 World Obesity Atlas report, more than half of the global population is projected to be overweight or obese by 2035 without significant intervention. In addition, the study published in NIH in 2023 found that obese women experience higher rates of specific types of fractures, such as thigh and ankle fractures, and lower rates of hip and wrist fractures, compared to postmenopausal women of normal weight.

Lower Extremity Implants Market Report Highlights:

• Based on type, the foot & ankle segment led the market with the largest revenue share of 48.88% in 2023, owing to the increasing incidence of foot and ankle fractures
• Based on biomaterial, the natural biomaterials segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the rising preference for biocompatible and bioresorbable materials
• Based on end use, the ASCs segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the increasing number of ASCs across the globe
• North America dominated the market with the revenue share of 48.8% in 2023, due to the presence of key market players. Furthermore, increasing prevalence of chronic diseases will supplement market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Biomaterial
  • 1.2.3. End use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Biomaterial outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Lower Extremity Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Lower Extremity Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Lower Extremity Implants Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Lower Extremity Implants Market: Type Movement Analysis
• 4.3. Lower Extremity Implants Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Knee
  • 4.5.1. Knee Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Hip
  • 4.6.1. Hip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Foot & Ankle
  • 4.7.1. Foot & ankle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Lower Extremity Implants Market: Biomaterial Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Lower Extremity Implants Market: Biomaterial Movement Analysis
• 5.3. Lower Extremity Implants Market by Biomaterial Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Metallic Biomaterials
  • 5.5.1. Metallic Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Ceramic Biomaterials
  • 5.6.1. Ceramic Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Polymeric Biomaterials
  • 5.7.1. Polymeric Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Natural Biomaterials
  • 5.8.1. Natural Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Lower Extremity Implants Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Lower Extremity Implants Market: End Use Movement Analysis
• 6.3. Lower Extremity Implants Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. ASCs
  • 6.6.1. ASCs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Clinics
  • 6.7.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Lower Extremity Implants Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Lower Extremity Implants Market movement analysis
• 7.3. Lower Extremity Implants Market: Regional Estimates & Trend Analysis by Type, Biomaterial & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Mexico Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. UK Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Germany Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. France Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Italy Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Spain Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Denmark Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.8. Norway
    • 7.6.8.1. Norway Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.9. Sweden
    • 7.6.9.1. Sweden Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Japan Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. China Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. India Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. South Korea Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Australia Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Thailand Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Brazil Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Argentina Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. South Africa Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Saudi Arabia Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. UAE Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Kuwait Lower Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Stryker
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Johnson & Johnson (DePuy Synthes)
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Zimmer Biomet
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Smith + Nephew
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Ossur
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. DJO Global
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Acumed, LLC
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Arthrex, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. CONMED
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Orthofix
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives